Absorbable Coronary Drug-Eluting Stent
FDA product code PNY · Class III (high risk) · Cardiovascular
An absorbable scaffold with a drug coating placed via a delivery catheter into the coronary artery or saphenous vein graft to maintain the lumen. The drug coating is intended to inhibit restenosis.
0510(k) clearances
1PMA approvals
1recalls
Implantimplanted device
PMA approvals
- P150023 Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System · Abbott Vascular, Inc. · 07/05/2016
Recalls
| Recall | Product | Firm | Initiated |
|---|---|---|---|
| Z-2151-2017 Class I | Absorb Bioresorbable Vascular Scaffold (BVS) system (Australia). The Absorb BVS is a…Abbott Vascular is initiating a recall of the Absorb Bioresorbable Vascular Scaffold (BVS) System due to… | Abbott Vascular | 04/26/2017Terminated |